Clinical Trial Update: Combination Chemotherapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating combination chemotherapy for stage IIIB, stage IV, or recurrent non-small cell lung cancer has been withdrawn from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lung Cancer | Phase 3 | Status: WITHDRAWN